Rhea Paul
Clinical language scientist / From Wikipedia, the free encyclopedia
Rhea Paul is an American clinical language scientist known for her work in the field of speech-language pathology. She was Founding Chair in the Department of Speech-Language Pathology in the College of Health Professions at Sacred Heart University and a research scientist and affiliate of Haskins Laboratories at Yale University.[1]
Rhea Paul | |
---|---|
Occupation(s) | Research scientist, speech pathologist |
Academic background | |
Alma mater | Brandeis University; Harvard University; University of Wisconsin–Madison |
Academic work | |
Institutions | Sacred Heart University; Haskins Laboratories |
Main interests | Language and Communication disorders, Autism Spectrum Disorder |
In 1997, Paul received the Editor's Award from the American Journal of Speech-Language Pathology[2] for her paper "Clinical implications of the natural history of slow expressive language development."[3] In 2010, Paul received the Slifka/Ritvo Innovation in Autism Research Award given by the International Society for Autism Research.[4] In 2014, she received Honors of the Association Award from the American Speech Language Hearing Association for her contributions to the field of communicative disorders.[5]